Maintaining Safety with SARS-CoV-2 Vaccines. Reply

N Engl J Med. 2021 Mar 11;384(10):e37. doi: 10.1056/NEJMc2100766. Epub 2021 Feb 10.

Authors

Mariana C Castells¹, Elizabeth J Phillips²

Affiliations

¹ Brigham and Women's Hospital, Boston, MA mcastells@bwh.harvard.edu.
² Vanderbilt University Medical Center, Nashville, TN.

PMID: 33567190
DOI: 10.1056/NEJMc2100766

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Viral
COVID-19 Vaccines
COVID-19*
Humans
SARS-CoV-2
Viral Vaccines*

Substances

Antibodies, Viral
COVID-19 Vaccines
Viral Vaccines